MorphoSys (MOR) Downgraded by Zacks Investment Research to Hold

MorphoSys stock has undergone multiple analysts rating changes in the recent past.  MorphoSys Downgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Strong-Buy.

Shares of MorphoSys traded down -$0.10 on Tuesday, reaching $11.19. 3270 shares of the stock traded hands, compared to its average volume of 63874. Shares of MorphoSys were trading at $11.19 on Tuesday. The firm’s 50 day moving average is $13.02 and its 200 day moving average is $20.55.MorphoSys has a 12 month low of $11.11 and a 12 month high of $30.75. While on yearly highs and lows, MorphoSys’s today has traded high as $11.33 and has touched $11.11 on the downward trend. See More Analyst Rating at: RATING

MorphoSys Earnings and What to expect: 

MorphoSys last released its earnings data on July 28th, 2021. The reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.48) by $0.66. The company had revenue of $46.06 million for the quarter, compared to analyst estimates of $46.02 million. MorphoSys has generated $0.85 earnings per share over the last year (($0.93) diluted earnings per share). Earnings for MorphoSys are expected to decrease in the coming year, from ($1.78) to ($2.45) per share. MorphoSys has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 11th, 2021 based off prior year’s report dates.

Earnings for MorphoSys are expected to decrease in the coming year, from ($1.78) to ($2.45) per share. The P/E ratio of MorphoSys is -12.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of MorphoSys is -12.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. MorphoSys has a P/B Ratio of 2.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

MorphoSys (MOR) Moving Average Technical Analysis

5 day Moving Average is $11.38 And 5 day price change is -$0.83 (-6.91%)  with average volume for 5 day average is 78,780. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $11.93 and 20 day price change is -$1.12 (-9.10%) and average 20 day moving volume is 69,980. 50 day moving average is $13.02  and 50 day price change is -$2.78 ( -19.90%)  and with average volume for 50 days is : 58,912. 200 day moving average is $20.55  and 200 day price change is -$16.20 (-59.15%)  and with average volume for 200 days is : 76,983.

Other owners latest trading in MorphoSys :

  • On 8/25/2021 shares held by Marshall Wace LLP were 10,342 which equates to market value of $0.20M and appx 0.00% owners of MorphoSys
  • On 8/23/2021 shares held by Morgan Stanley were 158,007 which equates to market value of $3.04M and appx 0.00% owners of MorphoSys
  • On 8/17/2021 shares held by Wells Fargo & Company MN were 11,491 which equates to market value of $0.22M and appx 0.00% owners of MorphoSys
  • In total Institutional ownership equates to Institutional Ownership Percentage: 1.71% for MorphoSys

See More Analyst Rating at: RATING